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Background: The question for prevalence estimation and validation of the various eGFRs in old age is still under
debate. To assess renal function with increasing age, we estimated mean eGFR, in subjects aged 20–85 years.
Furthermore, we assessed prevalence of eGFR in a population-based sample of 85 year olds and investigated the
performance of these eGFRs in predicting mortality in the oldest old.
Methods: Renal function with increasing age was assessed in subjects aged 20–85 years from the Bronovo Study
Cohort. We estimated prevalences of eGFRs and mortality risks in a population-based study of persons aged
85 years and older, the Leiden 85-plus Study. The GFRs were estimated by three different formulas.
Results: After the age of 70 years, the C-G tended to give relatively lower eGFRs. An eGFR < 60 was found in 90%
of the subjects aged 85 years as calculated by C-G, in 55% of the subjects using MDRD and in 68% of the 85 year
old subjects as calculated by CKD-EPI. When renal function was <30 ml/min/1.73 m2, an increased mortality risk was
observed by C-G (HR 1.9 (95% CI 1.1-3.3)), by MDRD (HR 3.5 (95% CI 1.8-6.7)), whereas by CKD-EPI significance was
not reached (HR 2.4 (95% CI 0.9-6.4)).
Conclusions: Our study demonstrates that in subjects above age 70, C-G gives lower estimates of renal function
when compared to MDRD and CKD-EPI. Furthermore, prevalence of renal dysfunction (CKD stage 1–3) at age
85 years was highest for C-G (90%), lowest for MDRD (55%), and 68% for CKD-EPI. Moreover, we found that in
subjects aged 85 years MDRD predicted mortality best.
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Chronic kidney disease (CKD) coinciding with impaired
renal function is predominantly a disease of the elderly
and is associated with an increased risk for all cause and
cardiovascular mortality, even after controlling for known
risk factors [1,2]. Furthermore, renal impairment also
affects safety of many common drugs used in older people.
The glomular filtration rate (GFR) is considered to be the
best overall reflection of renal function, but is not easily
measured in daily practice. Therefore creatinine clearance
is usually assessed by the classic Cockroft-Gault formula* Correspondence: j.m.willems@lumc.nl
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reproduction in any medium, provided the or(C-G) and an estimate of glomerular filtration rate is often
calculated by the Modification of Diet and Renal Disease
equation (MDRD) [3,4]. More recently the Chronic Kid-
ney Disease Epidemiology Collaboration equation (CKD-
EPI) has been suggested as a more accurate estimate of
eGFR [5], especially in the relative high ranges of eGFR
(CKD stage 1 and 2) [6,7]. However, these measures have
not been used to assess the impact of eGFR on truly esti-
mating renal function in older populations, and they are
not well validated in the elderly. Since it is difficult to
measure GFR in a large population based group of old
people, the question of prevalence estimation and valid-
ation of the various eGFRs in this age group is still
unanswered.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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GFR, an important characteristic of the C-G formula is
the inclusion of total body weight in the equation, as a
reflection of muscle mass, the main determinant of
creatinine generation [3]. With increasing age, body
composition changes with decreasing muscle mass and
increasing fat tissue as characteristic features, resulting
in decreased lean body mass in very old age [8,9]. These
age related changes might have important effects on
creatinine clearance as calculated by the C-G formula in
older individuals. In contrast to the classic C-G formula,
the MDRD and CKD-EPI equations incorporates body
surface area, resulting in eGFRs per 1,73 m2 body sur-
face area.
Since it is virtually impossible to validate the various
eGFRs in large population based samples of oldest old
people by measuring GFR, for example by creatinine or
inulin clearance, it is of great importance to determine
the best measure of GFR in older people. First, to assess
renal function with increasing age, we estimated mean
creatinine clearance by C-G, and eGFR by MDRD and
CKD-EPI equations, in 10 year age groups of subjects
aged 20–85 years. Then, we estimated prevalence of
eGFR in a population-based sample of 85 year olds and
investigated the performance of these eGFRs in predict-
ing mortality in the oldest old.
Methods
Study population
To investigate renal function as calculated by the C-G,
MDRD and CKD-EPI equations, a cohort of subjects
aged 20 to 85 years was used (study 1). This cohort was
originally established to set reference values for laboratory
measurements for various age categories in the Bronovo
Hospital, The Hague, The Netherlands [10,11], a general
hospital affiliated with Leiden University Medical Center,
Leiden, The Netherlands. There were no inclusion criteria.
Exclusion criteria were pregnancy, diabetes mellitus, use










*Serum creatinine is stated in μmol/L.
Abbreviations: eGFR estimated glomerular filtration rate, MDRD modification of diet in
Because all our individuals were of the Caucasian race the multiplier factor for raceoral anti-coagulants. From all participants a venous blood
sample was drawn. The Medical Ethical Committee of
Bronovo Hospital accorded the study and all participants
provided informed consent to study participation.
For studying prevalence of renal dysfunction based on
the three formulas and their performance in predicting
all cause mortality, the population of the Leiden 85-plus
Study was used (study 2). The Leiden 85-plus Study is a
population-based prospective follow-up study of persons
aged 85 years and older. There were no selection criteria
other than age. At baseline, all individuals were living in
Leiden, The Netherlands. A total number of 599 subjects
(response rate 87%) agreed to participate [12]. All par-
ticipants were visited at their place of residence where
interviews took place, height and weight measurements
were done and venous blood samples were drawn. After
inclusion all subjects were followed for mortality until
February 2009. The Medical Ethical Committee of the
Leiden University Medical Center (LUMC) approved the
study and all participants provided informed consent for
study participation.
Laboratory measurements
All blood samples were collected in sterile EDTA tubes.
Plasma creatinine concentrations were determined in
the Bronovo Hospital (study 1) with Synchron LX-20,
Beckman Coulter and in the LUMC (study 2) according
to the Jaffe method using Hitachi 747, Tokyo, Japan.
Creatinine clearance and glomular filtration rate equations
Three equations for renal function were used in our ana-
lysis (Table 1): the Cockcroft-Gault formula (C-G) [3],
the four variable Modification of Diet in Renal Disease
equation (MDRD) [4], and the Chronic Kidney Disease
Epidemiology Collaboration equation (CKD-EPI) [5].
Chronic kidney disease
CKD was defined according to the K/DOQI staging [13].
CKD stage 3 has been sub-divided into 30–44 (stage 3a)* eGFR (ml/min/1.73 m2)
((140- age) × bodyweight/serum creatinine) × 0.85
(140- age) × bodyweight/serum creatinine
175 × (serum creatinine/88.4)- 1.154 × age-0.203 × 0.742
175 × (serum creatinine/88.4)- 1.154 × age-0.203
144 × (serum creatinine/88.4/0.7)-0.329 × (0.993)age
144 × (serum creatinine/88.4/0.7)-1.209 x (0.993)age
141 × (serum creatinine/88.4/0.7)-0.411 × (0.993)age
141 × (serum creatinine/88.4/0.7)- 1.209 × (0.993)age
renal disease formula, CKD-EPI chronic kidney disease epidemiology equation.
was not applied.
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of graded increase in mortality risk (Table 2) [14,15].
Mortality
Mortality data of the Leiden 85-plus Study (study 2),
recorded between the start of the study, 1 September
1997, and 1 February 2009, were obtained from the mu-
nicipal registry, which are publicly available. For the
deceased participants the cause of death was obtained
from Statistics Netherlands. We obtained permission to
collect this data and only the primary cause of death on
the death certificate was used in our analyses.
Statistical analyses
Data are presented as number (percentages) for clinical
characteristics and as median (interquartile range) for
continuous parameters. The association between mea-
sures of renal function and mortality was analyzed with
sex-adjusted Cox proportional hazard models. Differences
in laboratory measurements between the different cat-
egories of eGFR as well as between sexes were determined
by Mann–Whitney tests. SPSS software (version 16.0.1,
SPSS Inc, Chicago, Ill) was used for statistical analyses.
P-values lower than 0.05 were considered statistically
significant.
Results
Creatinine clearance and eGFR in subjects aged 20–85
years (study 1)
Characteristics of subjects in study 1 are reported in
Table 3. The study sample comprised 242 subjects, 125
(52%) women and 117 (48%) men. In subjects aged 21 to
30 years, mean creatinine clearance as calculated by
Cockroft-Gault formula was 117 ml/min, mean eGFR by
MDRD formula was 94 ml/min/1.73 m2 and by CKD-
EPI equation was 104 ml/min/1.73 m2. In the oldest age
category, 71–85 years, creatinine clearance calculated by
Cockroft-Gault formula was 57 ml/min, eGFR by MDRD
formula 69 ml/min/1.73 m2 and by CKD-EPI equation
65 ml/min/1.73 m2. With increasing age, a significant
decline of renal function was observed in C-G, MDRD
and CKD-EPI (all p < 0.01). Figure 1 shows estimates of
mean renal function as assessed with C-G, MDRD and
CKD-EPI in the age categories. The three lines of theTable 2 Stages of chronic kidney disease
GFR CKD stage
≥ 60 Stage 1 and 2
45–59 Stage 3a
30–44 Stage 3b
< 30 Stage 4 and 5
Adapted from K/DOQI clinical practice guidelines [13].
GFR is stated in ml/min/1.73 m2.
CKD stage 3 has been sub-divided into 30–44 (stage 3b) and 45–59 ml/min/1.73m2C-G, MDRD, and CKD-EPI cross at age 70 years. Before
the age of 70 years, renal function as assessed by C-G is
above the MDRD and CKD-EPI, indicating that before age
70 years eGFR assessed with the C-G formula tends to
give relatively higher eGFRs. After the age of 70 years, the
line of the renal function as assessed with the C-G
formula is below the MDRD and CKD-EPI, indicating that
after age 70 years, eGFRs assessed with the C-G formula
tend to give relatively lower eGFRs.
Prevalence of renal dysfunction in the oldest old (study 2)
Characteristics of subjects in study 2 are reported in
Table 4. Sixty-seven percent of the subjects was female
and 30% had no comorbid illness. Median weight of all
subjects was 69.5 kg and the median body mass index
(BMI) was 26.7 kg/m2. Median creatinine clearance,
calculated by C-G, was 43 ml/min. Using this formula, in
496/550 subjects (90%) a creatinine clearance lower than
60 ml/min was found. Furthermore, of these 85 years old
subjects, the median eGFR, as calculated by MDRD, was
58 ml/min/1.73 m2 and 308/562 subjects (55%) were hav-
ing an eGFR lower than 60 ml/min/1.73 m2. Moreover,
when calculating GFR by CKD-EPI formula, a median
eGFR of 53 ml/min/1.73 m2 was found and in 383/562
subjects (68%) eGFR was under 60 ml/min/1.73 m2.
We determined the proportion of subjects in the
various categories of renal function, calculated by C-G,
MDRD and CKD-EPI. Figure 2 illustrates that the C-G
estimates result in higher prevalences of renal failure
compared to MDRD and CKD-EPI.
Reclassification of subjects in the various eGFR cate-
gories assessed by MDRD and CKD-EPI is shown in
Table 5. When the MDRD formula was used, 308/562
(54.8%) subjects were labelled as CKD stage 3 or worse
(eGFR < 60 ml/min/1.73 m2). When the CKD-EPI formula
was used, 383/562 (68.1%) subjects were classified as CKD
stage 3 or worse. Overall, 92 subjects moved up one CKD
stage when MDRD was used in stead of CKD-EPI. There
were no subjects that moved up when CKD-EPI was
used in stead of MDRD. The largest reclassification was
for the subjects within the CKD-EPI category 30–59
ml/min/1.73 m2. Of the 365 subjects within this cat-
egory, 75 were reclassified into the MDRD category
60–89 ml/min/1.73 m2.Description
Kidney damage with normal or mildly decreased GFR
Moderately decreased GFR
Moderately decreased GFR
Severely decreased GFR or kidney failure
(stage 3a) as there is evidence of graded increase in mortality risk [9,14].
Table 3 Characteristics of the Bronovo study cohort (study 1)
Age category (years)
21–30 31–40 41–50 51–60 61–70 71–85
(n = 42) (n = 43) (n = 43) (n = 52) (n = 41) (n = 21)
Female, n (%) 23 (55) 22 (51) 23 (54) 25 (50) 23 (56) 9 (43)
Creatinine (μmol/L) 76 (71–87) 85 (74–91) 82 (72–97) 86 (74–99) 83 (74–93) 87 (76–97)
Cockroft-Gault (ml/min) 117 (97–127) 112 (95–138) 97 (82–112) 87 (77–96) 78 (68–85) 57 (52–82)
MDRD (ml/min/1.73 m2) 94 (85–102) 86 (77–92) 78 (72–87) 75 (66–84) 72 (66–82) 69 (58–77)
CKD-EPI (ml/min/1.73 m2) 104 (93–111) 93 (83–99) 82 (75–92) 78 (68–87) 71 (65–83) 65 (54–73)
Data presented are as median (IQR), unless otherwise stated.
Abbreviations: MDRD Modification of Diet in Renal Disease equation, CKD-EPI Chronic Kidney Disease Epidemiology Equation.




Comorbid illness 398 (70)
Institutionalized 104 (18)
MMSE 26 (22–28)
Weight (kg) 69.5 (61.5–78.3)
Length (cm) 159 (154–166)
Body mass index (weigth/m2) 26.7 (24.2–29.9)
Body surface area (m2)* 1.72 (1.61–1.85)
Serum creatinine (μmol/L) 92 (81–108)
Cockroft-Gault (ml/min)∫ 43 (37–51)
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mortality risk are shown in Table 6. For the calculations
of the mortality risk, eGFRs above 60 ml/min/1.73 m2
were set as reference group. With the C-G formula, an
almost twofold increased risk for all-cause mortality was
found for subjects with a renal function lower than
30 ml/min/1.73 m2 (HR 1.9 (95% CI 1.1-3.3)). An in-
creased mortality risk was also observed by calculat-
ing renal function by MDRD, when renal function was
under 30 ml/min/1.73 m2 (HR 3.5 (95% CI 1.8-6.7), and
when renal function was between 30–44 ml/min/1.73 m2
(HR 1.6 (95% CI 1.2-2.2). When renal function was esti-
mated with CKD-EPI, subjects with renal function lower
than 30 ml/min/1.73 m2 had a similar increased all-cause
mortality risk compared to MDRD, but significance was
just not reached, HR 2.4 (95% CI 0.9-6.4).
Discussion
The results of our study are threefold. First, our study
demonstrates that in subjects under age 70 years, C-G
gives higher estimates of renal function when compared to
MDRD and CKD-EPI, while in subjects above age 70, C-G
gives lower estimates of renal function when compared toFigure 1 Renal function in subjects of different age categories.
Modification of Diet in Renal Disease (MDRD) clearance and Chronic
Kidney Disease Epidemiology Collaboration clearance (CKD-EPI) are
expressed in ml/min/1.73 m2 and Cockroft-Gault (C-G) clearance
in ml/min.MDRD and CKD-EPI. Second, prevalence of renal dys-
function (CKD stage 3–5) at age 85 years was highest for
C-G (90%), lowest for MDRD (55%), and 68% for CKD-
EPI. Third, we found that in subjects aged 85 years MDRD
predicted mortality best. These results suggest that at very
old age the MDRD formula might be the best estimate for
eGFR, since the MDRD formula is most discriminative in
predicting mortality.>60 ml/min 54 (10)
30–60 ml/min 454 (83)
<30 ml/min 42 (7)
MDRD (ml/min/1.73 m2) 58 (49–68)
>60 ml/min/1.73 m2 254 (45)
30–60 ml/min/1.73 m2 298 (53)
<30 ml/min/1.73 m2 10 (2)
CKD-EPI (ml/min/1.73 m2) 53 (46–62)
>60 ml/min/1.73 m2 179 (32)
30–60 ml/min/1.73 m2 365 (65)
<30 ml/min/1.73 m2 18 (3)
Continuous parameters are presented as median (IQR).
Categorial data are presented as number (%).
*Body Surface Area = calculated by DuBois’s formula.
∫ in 12 subjects weight was not available to calculate Cockroft-Gault clearance.
Abbreviations: MMSE Mini Mental State Examination, MDRD Modification of
























Figure 2 Proportion of subjects in the various categories of
eGFRs, calculated by C-G, MDRD and CKD-EPI. Abbreviations: C-
G; Cockroft-Gault formula, MDRD; Modification of Diet in Renal Dis-
ease, CKD-EPI; Chronic Kidney Disease Epidemiology
Collaboration clearance.
Table 6 Relative mortality risks in categories of eGFR for
C-G, MDRD and CKD-EPI
Hazard ratio (95% CI)
< 30 ml/min 30-44 ml/min 45-59 ml/min >60 ml/min
C-G 1.9 (1.1-3.3)* 1.3 (0.9-1.9) 1.0 (0.7-1.5) 1
MDRD 3.5 (1.8-6.7)** 1.6 (1.2-2.2)** 1.1 (0.9-1.3) 1
CKD-EPI 2.4 (0.9-6.4) 1.3 (0.9-1.8) 1.1 (0.9-1.5) 1
All hazard ratios are adjusted for sex.
C-G clearance is in ml/min, MDRD and CKD-EPI clearance is in ml/min/1.73 m2.
Abbreviations: C-G Cockcroft-Gault, MDRD Modification of Diet in Renal Disease,
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration clearance.
*P < 0.05, ** P ≤ 0.01 compared to the reference group (>60 ml/min).
Willems et al. BMC Geriatrics 2013, 13:113 Page 5 of 7
http://www.biomedcentral.com/1471-2318/13/113eGFR in various age categories
We showed that C-G, MDRD and CKD-EPI formula
provide different estimates of renal function in various
age categories. Under the age of 70, C-G clearance
relatively overestimated renal function compared to
eGFRs calculated by both MDRD clearance and CKD-
EPI, whereas above the age of 70 creatinine clearance
assessed with C-G formula resulted in relatively lower
values. Our results are in line with earlier studies with
older individuals (all mean age <85 years) [16,17], and
also comparable with another community based study
with younger participants (mean age of 75 years) [18].
The difference in mean age of the participants is the
most plausible explanation between these study findings.
The discrepancy in renal function calculated by the C-G
formula and the MDRD and CKD-EPI equations may be
explained by the intrinsic design of the estimates. In
comparison with the MDRD and CKD-EPI equations, in
the C-G formula the body weight is included next to theTable 5 Number of subjects in categories of CKD assessed
by MDRD and CKD-EPI
MDRD
CKD-EPI <15 15-29 30-59 60-89 >90
<15 2 0 0 0 0 2
15-29 0 8 8 0 0 16
30-59 0 0 290 75 0 365
60-89 0 0 0 170 9 179
>90 0 0 0 0 0 0
Total 2 8 298 245 9 562
Numbers in bold indicate those subjects who do not change CKD category on
the basis of eGFR assessed with MDRD and CKD-EPI. Italic figures indicate the
numbers of subjects who change into a different CKD stage.
MDRD and CKD-EPI clearance are stated in ml/min/1.73 m2.
Abbreviations: CKD Chronic Kidney Disease, MDRD Modification of Diet in
Renal Disease, CKD-EPI Chronic Kidney Disease Epidemiology
Collaboration clearance.creatinine and age. In old age, lean body mass is reduced
secondary to both sarcopenia and to increasing fat tissue
[8,9]. The MDRD and CKD-EPI equations are adjusted
for body surface area (BSA)[19], resulting in an eGFR
value per 1.73 m2 BSA. Therefore, ageing may also have
an effect on this adjusted eGFR since, next to the
changes in body weight, both women and men loose
height with increasing age, resulting in a decline in BSA
in old age [20]. In the Leiden 85-plus Study mean BSA
was 1.72 m2, suggesting that the BSA adjustment used
in the MDRD and CKD-EPI estimates may, however, be
appropriate in this very old population. It may be ques-
tioned whether it is appropriate to index the C-G
formula for BSA, because weight is already included in
the equation as a variable. Therefore, the use of the C-G
formula in clinical practice for very old individuals is
questionable.
eGFR in the oldest old
Recently, the CKD-EPI, has been introduced in clinical
practice, because of the possible inadequacies of the C-G
and MDRD equations [4,5]. Our study shows that imple-
mentation of the CKD-EPI formula has consequences
for very old subjects. Above the age of 70, eGFR calcu-
lated by CKD-EPI formula is underestimating renal
function in comparison with eGFR calculated by MDRD,
although not as much as the C-G formula. Compared
with the classic C-G equation, introduction of the CKD-
EPI formula will lower the amount of older individuals
with CKD. Whereas based on these results, implemen-
tation of CKD-EPI formula would raise the number of
older individuals with CKD on the basis of eGFR esti-
mated with the MDRD formula, with as a consequence
more hospitalizations, costs and also other therapeutic
implications. A recently published large population
based study of over a half million UK people of all ages
[21] found that introduction of the CKD-EPI formula
would reduce the prevalence of CKD in subjects < 70
years, but would raise the prevalence of CKD in the over
70 year old group. Furthermore, another report with
particular emphasis of eGFR and the effect of age found
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crease CKD prevalence estimates [22]. Although there
are several studies with younger individuals that suggest
that the CKD-EPI equation more accurately categorizes
individuals [5,7] and although the US National Kidney
Foundation has already recommended the adoption of
the CKD-EPI formula for routine eGFR reporting by
laboratories in the USA [23], based on our results and
others [21,22,24-26], more research in the older individ-
uals is warranted, before the CKD-EPI can be imple-
mented in clinical practice for the oldest old age
categories, in order to prevent unnecessary diagnostic
procedures, therapeutic interventions and medical costs.
Mortality risks and eGFR at old age
Since one goal of estimating renal function in clinical
practice is to obtain estimates of deaths risk in various
stages of CKD, it seems logical to use the equation that
provides the best prediction of these outcome, especially
in older individuals [1,2]. Therefore, we examined the as-
sociation between the three different assessment methods
for renal function and mortality in old age and found the
MDRD equation to be best predictive for mortality. Sub-
jects with MDRD< 45 ml/min/1.73 m2 had higher mortal-
ity risks compared to renal function calculatd by C-G or
CKD-EPI formulae. Moreover, in subjects with creatinine
clearance < 30 ml/min/1.73 m2 calculated by MDRD for-
mula, a 3.5 increased risk of mortality was found. Our
findings are in contrast with a large Italian study of 942
community dwelling subjects [18]. The participants of this
study, the InCHIANTI study, had a mean age of 75 years.
They found that only the C-G and not the MDRD
equation was predictive for mortality. Since estimating
equations C-G and MDRD both incorporate age in the
formula, a plausible explanation for the discrepancy
between findings of the two studies is the difference in
mean age of the participants. In our study we only
included oldest old subjects, all aged 85 years. However, a
study with hospitalized older individuals in The Netherlands
(mean age 78 year) showed results similar to ours [27].
Furthermore, in line with our findings, a large British
cohort study of people aged 75 years and older, showed a
increased mortality risk with MDRD< 45 ml/min/1.73 m2
[15]. Data of very old community-dwelling very subjects
(≥ 85 years) and the prediction of all cause mortality by
C-G and especially MDRD and CKD-EPI formulae
are scarce.
Strong points and limitations
This is one of the few studies evaluating the effect of
three different estimation methods for renal function in
very old individuals in a population-based setting with a
very high participation rate (87%) and with complete
follow-up. This permits us to generalize our conclusionsto very old people in the general population at large.
Unfortunately, in both study cohorts, we did not have
24-hour urine collections for the measurement of
creatinine clearance, although accuracy of urine collec-
tion at home done in a very old study population can be
discussed. Moreover, accurate GFR measurements using
inulin or iothalamate infusions are undoable for large
scale study populations.Conclusions
In conclusion, estimation of renal function in very old
persons can be facilitated by GFR equations, although
C-G, MDRD and CKD-EPI all have their own limita-
tions. We found that after age 70 years, C-G gives lower
eGFRs and might therefore overestimating the number
of individuals having CKD in comparison with both
MDRD and CKD-EPI after the age of 70 years. More-
over, our results suggest that the MDRD formula might
be the best estimate for eGFR in the oldest old followed
by the CKD-EPI formula, since the MDRD formula is
the best in predicting mortality. Our study suggests that
implementation of CKD-EPI formula would raise the
number of older individuals with CKD in comparison
with the MDRD formula, with consequences for thera-
peutic decision making procedures and resulting in more
referrals to nephrologists. Therefore, more research in
older individuals is urgently needed, before the CKD-EPI
can be implemented in clinical practice for the oldest
old age categories.
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